Cost-Cutting Generics and Biosimilars Stuck in Legal Limbo
July 21, 2021
Khadijah Silver
MedCity News
Axinn partner Chad Landmon was quoted in the MedCity News article, "Cost-Cutting Generics and Biosimilars Stuck in Legal Limbo."
Click here to access the article.